Endogenous growth factors and cytokines are known to have a major influence
on the progression, motility and invasiveness of tumor cells. We have repo
rted previously that conditioned media from mouse fibroblasts increases the
motility of breast cancer cells. Further, we determined that keratinocyte
growth factor (KGF) was an active factor from mouse fibroblasts responsible
for most of the motility response in breast cancer cells. The present stud
y examined the effect of human KGF on the motility of estrogen receptor (ER
)-positive and ER-negative human breast cancer cell lines in culture using
time-lapse videomicroscopy to quantify cell motility. In the present study
we observed that recombinant human KGF enhanced several parameters of cellu
lar motility in ER-positive cells but not in ER-negative cell lines. Furthe
r, we observed that the level of KGF receptor (KGFR) expression in ER-posit
ive cells was much greater than in the ER-negative cell lines. The motility
response to KGF was found to be both dose-and time-dependent. Of the three
ER-positive breast cancer cell lines tested, MCF-7 cells were the most res
ponsive to KGF stimulation. Finally, MCF-7 cells grown in estrogen-depleted
media did not respond to KGF. These results suggest that KGF from stromal
tissue surrounding a primary tumor mass can enhance tumor cell motility and
may be an early signal in the progression of breast cancer cells to a more
motile and metastatic phenotype. Thus, KGF, KGFR and/or the KGF signaling
pathway may be important therapeutic targets for the treatment or preventio
n of breast cancer metastasis.